Sign Up to like & get
recommendations!
0
Published in 2018 at "Journal of cardiology"
DOI: 10.1016/j.jjcc.2018.01.015
Abstract: BACKGROUND To evaluate the efficacy and safety of non-vitamin K antagonist oral anticoagulants (NOACs) in elderly patients (aged ≥75 years) with atrial fibrillation (AF), depending on dose and/or renal function. METHODS After systematically searching the…
read more here.
Keywords:
warfarin elderly;
better efficacy;
safety;
compared warfarin ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Seminars in thoracic and cardiovascular surgery"
DOI: 10.1053/j.semtcvs.2021.05.011
Abstract: The evidence for use of direct oral anticoagulants (DOACs) in the management of post-operative cardiac surgery atrial fibrillation (POAF) is limited and mostly founded on clinical trials that excluded this patient population. We performed a…
read more here.
Keywords:
atrial fibrillation;
surgery;
compared warfarin;
cardiac surgery ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "Medical Care"
DOI: 10.1097/mlr.0000000000000901
Abstract: Background: It remains unclear whether the use of new oral anticoagulants, compared with warfarin, is economically beneficial in Asian countries. Objective: The objective of this study is to compare the health care costs and utilization…
read more here.
Keywords:
health care;
care costs;
compared warfarin;
dabigatran ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "European Journal of Haematology"
DOI: 10.1111/ejh.13599
Abstract: Data on the safety of apixaban compared to warfarin in hemodialysis (HD) patients are accumulating, but the impact of concomitant antiplatelet use is unknown.
read more here.
Keywords:
apixaban compared;
warfarin hemodialysis;
compared warfarin;
safety apixaban ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "Heart"
DOI: 10.1136/heartjnl-2018-313351
Abstract: Objectives Compare the effect of apixaban and warfarin on coagulation and primary haemostasis biomarkers in atrial fibrillation (AF). Methods The biomarker substudy from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial…
read more here.
Keywords:
atrial fibrillation;
apixaban compared;
treatment;
effect apixaban ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2023 at "Frontiers in Cardiovascular Medicine"
DOI: 10.3389/fcvm.2023.1040834
Abstract: Background Further studies are needed to expand the evidence for the association of rivaroxaban with a lower risk of adverse renal outcomes in patients with atrial fibrillation (AF) as compared with warfarin, especially in Asians.…
read more here.
Keywords:
outcomes rivaroxaban;
kidney;
compared warfarin;
renal outcomes ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2023 at "International Journal of Environmental Research and Public Health"
DOI: 10.3390/ijerph20043176
Abstract: Background: Direct oral anticoagulants (DOACs) have been used for venous thromboembolism (VTE) in Thailand. However, they have not been listed in the National List of Essential Medicines (NLEM). A cost-effectiveness analysis is needed to aid…
read more here.
Keywords:
compared warfarin;
cost;
qaly;
analysis ... See more keywords